Skip to main content
Download PDF
Download ePub

Identification of LINC02454-related key pathways and genes in papillary thyroid cancer by weighted gene coexpression network analysis (WGCNA)

Thyroid Research volume 17, Article number: 17 (2024) Cite this article

Abstract

Background

Our previous study demonstrated that long intergenic noncoding RNA 02454 (LINC02454) may act as an oncogene to promote the proliferation and inhibit the apoptosis of papillary thyroid cancer (PTC) cells. This study was designed to investigate the mechanisms whereby LINC02454 is related to PTC tumorigenesis.

Methods

Thyroid cancer RNA sequence data were obtained from The Cancer Genome Atlas (TCGA) database. Weighted gene coexpression network analysis (WGCNA) was applied to identify modules closely associated with PTC. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis was used to identify the key pathways, and the maximal clique centrality (MCC) topological method was used to identify the hub genes. The Gene Expression Profiling Interactive Analysis (GEPIA) database was used to compare expression levels of key genes between PTC samples and normal samples and explore the prognostic value of key genes. The key genes were further validated with GEO dataset.

Results

The top 5000 variable genes were investigated, followed by an analysis of 8 modules, and the turquoise module was the most positively correlated with the clinical stage of PTC. KEGG pathway analysis found the top two pathways of the ECM − receptor interaction and MAPK signaling pathway. In addition, five key genes (FN1, LAMB3, ITGA3, SDC4, and IL1RAP) were identified through the MCC algorithm and KEGG analysis. The expression levels of the five key genes were significantly upregulated in thyroid cancer in both TCGA and GEO datasets, and of these five genes, FN1 and ITGA3 were associated with poor disease-free prognosis.

Conclusions

Our study identified five key genes and two key pathways associated with LINC02454, which might shed light on the underlying mechanism of LINC02454 action in PTC.

Introduction

Thyroid cancer is the most common endocrine cancer worldwide, with an estimated 44 020 cases and 2170 deaths in 2024 [1]. Thyroid cancer ranks ninth in global cancer incidence [2]. Thyroid cancer exhibits a distinct gender predilection, with females accounting for approximately 75% of all cases [2, 3]. Additionally, the disease can occur across a wide age spectrum, though the median age at diagnosis is the early 50s. Notably, thyroid cancer is the most prevalent malignancy among adolescents and young adults aged 16–33 years [4]. Approximately 84% of thyroid cancer cases are papillary thyroid cancer (PTC), with an estimated 5-year survival of 98.5% [5]. However, aggressive variants of PTC and advanced TNM stage can still threaten the patients' quality of life. Thirty percent of thyroid cancers will not carry any of the known mutations involved in thyroid cancer initiation and progression (RAS, RET/PTC, or BRAF (V600E) mutations) [6]. Thus, it is important to identify novel molecular pathways associated with the progression and prognosis of thyroid cancer.

Recently, long noncoding RNAs (lncRNAs) have been found to have a key role in cancer development and progression including thyroid cancer. This has led investigators to focus on lncRNAs as diagnostic and prognostic thyroid cancer biomarkers. For example, Gugnoni et al. found that Linc00941 was upregulated in PTC, and its expression level was correlated with aggressive features in PTC patients [7]. Furthermore, recent work by Guo et al. revealed that lncRNA-MIAT was overexpressed in PTC tissues and impacted cellular proliferation, migration and invasion by regulating by sponging miR-150-5p [8]. Our previous lncRNA expression microarray profiling study reported that many lncRNAs were aberrantly expressed in PTC tissues. Among them, a novel long intergenic noncoding RNA 02454 (LINC02454) was markedly overexpressed in PTC tissues. Functional studies in PTC cells demonstrated that LINC02454 impacted cellular apoptosis and proliferation. Moreover, we found that high LINC02454 expression level was associated with advanced clinical stage and poor disease-free survival in patients with PTC [9]. Furthermore, Cao et al. demonstrated that upregulation of LINC02454 cis-regulated HMGA2 expression by facilitating CREB1 phosphorylation and nuclear translocation, and HMGA2 promoted LINC02454 expression by binding its promoter, thereby accelerating thyroid carcinoma colony formation, migration, invasion, and EMT [10]. Current research on the functional implications of LINC02454 in malignancies other than PTC is limited. Chen et al. have shown that LINC02454, transcriptionally regulated by EGR1, interacts with the CCT complex to modulate TERT expression, maintaining telomere homeostasis and promoting oncogenesis in head and neck squamous cell carcinoma [11]. In addition, LINC02454 was identified as a crucial regulator of laryngeal squamous cell carcinoma progression, promoting cell proliferation, migration, and invasion. Notably, LINC02454 protected laryngeal squamous cell carcinoma cells from copper-induced mitochondrial damage, suggesting its potential as a therapeutic target [12]. However, the possible mechanism of LINC02454 in PTC remains unknown.

Weighted correlation network analysis (WGCNA) can be used for finding clusters (modules) of highly correlated genes, for summarizing such clusters using the module eigengene or an intramodular hub gene (genes with high connectivity in the module), for relating modules to one another and to external sample traits (using eigengene network methodology), and for calculating module membership measures. Correlation networks facilitate network-based gene screening methods that can be used to identify candidate biomarkers or therapeutic targets. These methods have been successfully applied in various biological contexts, e.g. cancer, mouse genetics, yeast genetics, and analysis of brain imaging data. Thus, in the present study, we sought to further explore how the key LINC02454-related pathways and key genes are involved in thyroid cancer oncogenesis by weighted gene coexpression network analysis (WGCNA).

Material and methods

Data source and preprocessing

Thyroid cancer RNA sequence expression data together with clinical feature data were obtained from The Cancer Genome Atlas database (TCGA, https://portal.gdc.cancer.gov/). The raw sequencing data were normalized using the voom function of the limma package in R. GSE150899 was collected from GEO (https://www.ncbi.nlm.nih.gov/geo/) to validate the differential expression of five key genes.

WGCNA network construction and module identification

The “WGCNA” R package was used to explore thyroid cancer-related modules with the dataset obtained from TCGA through the following steps: (i) The median absolute deviation (MAD) in the expression level of each gene was calculated, top 5000 genes with highest MAD were selected for further analysis. (ii) The hclust function of R was used to perform cluster analysis on these samples. (iii) Soft-thresholding was performed for network topology construction, and the appropriate power value was used to construct the network. (iv) Hierarchical clustering and the dynamic tree cutting algorithm were used to detect gene coexpression modules, which were given different colors for visualization. (v) Module-trait associations were examined using the Pearson correlation between the module eigengene and the clinical traits.

Functional and pathway enrichment analysis

The clusterProfiler R package was utilized to perform Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis of candidate genes obtained from WGCNA. Pathways with q value < 0.2 and p value < 0.05 were defined as significantly enriched.

Co-expressed genes network construction and key gene identification

The coexpressed genes pairs in modules were filter with threshold of 0.1 according to weight. The coexpressed network was constructed and visualized by Cytoscape software (version 3.6.1). Hub genes were identified by MCC topological analysis methods using the Cytoscape plugin cytoHubba. The key genes were defined as the intersection among hub genes identified by MCC in whole coexpression network, LINC02454 coexpressed genes in network and genes in top10 significantly enriched KEGG pathways.

Validation of key genes in the GEPIA database and GEO dataset

The online database Gene Expression Profiling Interactive Analysis (GEPIA, http://gepia.cancer-pku.cn/) was used to compare expression levels of key genes between thyroid cancer samples and normal samples based on TCGA normal and GTEx data. ANOVA was used to analyze the differentially expressed genes, which were those with |log2FC| values > 1 and q values < 0.01. GEPIA was also applied to explore the prognostic value of key genes though disease-free survival (DFS) curves using the Kaplan‒Meier method with a 50% (median) cutoff and were compared by the log rank test. P values < 0.05 were considered statistically significant. The expression level of key genes was also checked in GEO dataset GSE150899.

All statistical analyses in this article were performed using R (4.1.10) and relevant R packages. P < 0.05 was considered significant. All asterisks in the text indicate significance, with the corresponding relationships being p < 0.0001****, p < 0.001***, p < 0.01**, p < 0.05 *, and p > 0.05 ns (not significant).

Results

Data collection

The strategy of bioinformatics analysis is performed as shown in Fig. 1. A total of 502 thyroid cancer samples were obtained from the TCGA database. Clinical information on thyroid cancer samples, such as sex, race, age, clinical stage and patient survival, was also complied. The boxplot displayed the normalized expression profile of 502 thyroid cancer samples (Supplementary Fig. 1). GEO dataset GSE150899 was utilized to validate the expression of 5 key genes.

Fig. 1
figure 1

Flow chart of this study design

Full size image

WGCNA network construction

The top 5000 genes with highest MAD were used to conduct WGCNA. To ensure that the identified coexpression module were reliable, hierarchical cluster analysis was performed to remove potential outliers. As shown in Fig. 2, there was no abnormal sample. The scale free topology index achieved 0.85 when soft threshold power β was set to 5, and there was a relatively high average connectivity (Fig. 3). Thus, the constructed network conformed to the power-law distribution and was close to the real biological network. Finally, gene dendrograms were obtained using average linkage hierarchical clustering. The dynamic tree cut yielded eight modules with corresponding colors (Fig. 4). The gene number per module and corresponding colors are shown in Table 1.

Fig. 2
figure 2

Sample clustering to detect outliers. All the samples were in the clusters, all samples have passed the cuts

Full size image
Fig. 3
figure 3

Analysis of network topology for various soft-threshold powers. The left panel shows the function of soft-threshold power on the scale-free topology fit index; the right panel displays the function of soft-threshold power on the mean connectivity

Full size image
Fig. 4
figure 4

Clustering dendrograms and color display of the co-expression network modules constructed by dissimilarity based on topological overlap. The dynamic tree cut yielded eight modules. Module colors are shown correspondingly

Full size image
Table 1 The number of genes in the eight modules
Full size table

Key module identification

To search for the most clinically relevant module, the relationships between the module eigengene and the clinical characteristics were depicted in a heat map (Fig. 5). It has been shown that the turquoise module was significantly correlated with the TMN stage, pathologic stage, lymph node count and positive lymph nodes of thyroid cancer. Table 1 showed that the turquoise module consisted of most genes (1619). LINC02454 was right in the turquoise (Supplementary Table 1). Therefore, the turquoise module was selected for further functional enrichment analysis.

Fig. 5
figure 5

Heatmap of module-trait relationships displaying correlations between module eigengenes and clinical characteristics. Numbers in the table correspond to the correlation coefficient and the p-value in bracket. The degree of correlation is illustrated with the color legend

Full size image

Key module functional enrichment analysis

A total of 1619 genes in the turquoise module were subjected to functional enrichment analyses. The top ten terms were selected for visualization. GO analysis indicated that the genes in the turquoise module were mainly enriched in reproductive structure development under biological processes, collagen − containing extracellular matrix under cellular component, and passive transmembrane transporter activity under molecular function (Fig. 6). The results of KEGG pathway analysis showed that the turquoise module regulated pathways included ECM − receptor interaction, MAPK signaling pathway, and proteoglycans in cancer (Fig. 7). Therefore, turquoise module may be associated with thyroid tumorigenesis.

Fig. 6
figure 6

Gene Ontology enrichment of gene clusters involved in the turquoise module regarding biological process, cellular component, and molecular function. The colored dots represent term enrichment: green indicates low significance, red indicates high significance. The size of the dots represents the number of genes in each Gene Ontology term

Full size image
Fig. 7
figure 7

Kyoto Encyclopedia of Genes and Genomes pathways enrichment analysis of gene clusters involved in the turquoise module. The colored dots represent term enrichment: blue indicates low significance, red indicates high significance. The size of the dots represents the number of genes in each Kyoto Encyclopedia of Genes and Genomes pathway

Full size image

Key gene identification

To investigate the role of LINC02454 in thyroid cancer tumorigenesis, we constructed coexpression gene network for turquoise module. The network consisted of 1460 nodes and 61,672 edges (Supplementary Fig. 2), which included 131 LINC02454-coexpressed genes (Supplementary Table 2, Fig. 8). 5 key genes (FN1, LAMB3, ITGA3, SDC4, and IL1RAP) were identified by intersecting these 131 genes with the top 40 hub genes from the network (Supplementary Table 3) identified by MCC method and genes in top 10 enriched KEGG pathways (Supplementary Table 4). Thus, these 5 key genes could be associated with the pathology of PTC and were selected for further analysis.

Fig. 8
figure 8

Co-expression network of 131 LINC02454-coexpressed gene. Intersection of top 40 hub genes and genes in top 10 enriched KEGG pathways are highlighted in yellow. LINC02454 is shaped in diamond

Full size image

Key genes expression level and survival analysis

Based on the data from GEPIA and TCGA, we found that fibronectin 1 (FN1), laminin subunit beta 3 (LAMB3), integrin subunit alpha 3 (ITGA3), syndecan-4 (SDC4), and IL1 receptor-associated protein (IL1RAP) were significantly overexpressed in thyroid cancer tissues compared with normal thyroid tissues (P < 0.01) (Fig. 9). The aberrant expression of these five key genes were also seen in GEO dataset GSE150899 (Fig. 10). The prognostic value of the 5 key genes were further investigated. As shown in Fig. 11A, PTC patients with high FN1 expression had significantly shorter DFS than those with low FN1 expression (P < 0.05). Likewise, high ITGA3 expression in PTC patients was associated with poor DFS (P < 0.05) (Fig. 9C). No significant association was observed between the other three key genes and disease-free survival (P > 0.05) (Fig. 11B, D and E).

Fig. 9
figure 9

The relative expression of 5 hub genes in thyroid cancer by GEPIA. A FN1. B LAMB3. C ITGA3. D SDC4. E IL1RAP. All 5 key genes were significantly upregulated in 512 PTC samples compared with 337normal thyroid samples. Red plots indicate tumor tissue and gray plots indicate normal tissue. *p < 0.01

Full size image
Fig. 10
figure 10

The relative expression of 5 hub genes in thyroid cancer in GSE150899. All 5 key genes were significantly upregulated in PTC samples compared with normal thyroid samples. Red indicates tumor tissue and blue indicates normal tissue. ****p < 0.0001

Full size image
Fig. 11
figure 11

Prognostic value of 5 hub gene expression levels using GEPIA in thyroid cancer. A FN1. B LAMB3. C ITGA3. D SDC4. E IL1RAP. Patients with high expression of FN1 demonstrated significantly shorter DFS than those with low level of FN1 expression (P = 0.024). Patients with high expression of ITGA3 demonstrated significantly shorter DFS than those with low level of ITGA3 expression (P = 0.013). No significant association was observed between the other three hub genes and DFS. Survival curves were compared using log-rank test. DFS, disease-free survival

Full size image

Discussion

In the present study, we discovered the potential pathways and LINC02454-coexpressed genes via WGCNA, giving some clues about the underlying mechanisms of LINC02454 in PTC. The ECM − receptor interaction and MAPK signaling pathway were considered the most significant potential key pathways. We found 131 LINC02454-coexpressed genes, of which FN1, LAMB3, ITGA3, SDC4, and IL1RAP were identified as key genes. Using the online GEPIA database, 5 key genes showed significantly higher expression levels in thyroid cancer tissues than in normal thyroid tissues, which was also confirmed with GEO dataset. More importantly, of these 5 genes, high FN1 and ITGA3 expression was negatively associated with DFS, indicating that FN1 and ITGA3 are considered poor prognostic indicators for PTC. Together, these findings indicate that 5 key genes could affect the ECM-receptor interaction and MAPK signaling pathway to promote PTC development.

The extracellular matrix (ECM) is a complex noncellular unit that is composed of different extracellular glycoproteins. Matrix components can directly interact with cellular receptors to regulate the proliferation, adhesion, migration, differentiation and metastasis of cells. Recent studies have shown that ECM-receptor interaction pathways play a crucial role in promoting tumorigenesis and metastasis in thyroid cancer and other human cancers [13,14,15,16]. The genes involved in ECM–receptor interaction pathways are frequently deregulated in cancer patients. Through GO analysis, we found that the differentially expressed genes were mainly enriched in the biological processes of extracellular structure organization, extracellular matrix organization and cell − substrate adhesion, indicating ECM-receptor interaction as a key pathway in thyroid carcinogenesis. FN1, a member of the glycoprotein family in the extracellular matrix, has been reported to regulate a variety of biological processes, including cell adhesion, migration and cell movement, in various malignant tumors. For example, a resent study reported that silencing FN1 inhibits YAP1/Hippo pathway activation by enhancing YAP1 phosphorylation, reduces aspartate uptake and utilization via SLC1A3, and suppresses breast cancer cell proliferation, invasion, migration and promotes apoptosis [17]. Another report indicated that the high expression value of FN1 was associated with significantly poor survival in pancreatic cancer [18]. Moreover, Jiang et al. reported that FN1 was upregulated in papillary PTC and regulated thyroid cancer cell migration, invasion and EMT. Mechanistically, depletion of FN1 rescued the effects of miR-142-3p inhibitor on cell proliferation, invasion, apoptosis and EMT by inactivating the FAK/ERK/PI3K signaling pathway [19]. Additionally, according to Nieto et al.’s research, FN1 was significantly upregulated in recurrent thyroid cancer and impacted cellular migration, highlighting it as a potential prognostic biomarker [20]. In agreement with the above, we found that FN1 was significantly upregulated in PTC. FN1 was the LINC02454-coexpressed gene that is involved in the ECM − receptor interaction pathway. More importantly, FN1 was also a significant predictor of DFS. Together, these findings indicate that FN1 may act as a new candidate prognostic biomarker for PTC patients.

ITGA3, belonging to the integrin family, has been reported to interact with extracellular matrix proteins and promote tumor cell proliferation, migration and survival [21]. Huang et al. noted that ITGA3, a critical integrin subunit, was upregulated in pancreatic cancer. High ITGA3 correlated with increased PD-L1, reduced CD8 + T cells, and unfavorable outcomes in patients receiving chemotherapy or immunotherapy [22]. In thyroid cancer, it has been reported that ITGA3 can govern PTC cell proliferation, invasion and migration and has been associated with recurrence and short survival [23, 24]. Although some functions of ITGA3 in PTC have been reported, the potential mechanisms of ITGA3 in PTC are still unknown. Consistent with the findings in those cancer types, we found that ITGA3 was highly expressed in PTC tissue, and patients with high ITGA3 expression showed a significantly poorer DFS. Through WGCNA and KEGG pathway analysis, we showed that ITGA3 was involved in the ECM–receptor interaction pathway associated with the poor prognosis of PTC patients.

Laminins are large extracellular glycoproteins comprised of three covalently linked chains (α, β, and γ) and are involved in several important biological processes of cellular differentiation, migration, adhesion, proliferation, and survival. LAMB3 encodes one of the three subunits of LM-332, an extracellular matrix protein secreted by cultured human keratinocytes. A number of studies have revealed that LAMB3 is involved in cellular invasion and metastasis processes in several tumor types. For example, recent research by Zhang et al. demonstrated that LAMB3 was overexpressed in cervical cancer and promoted cancer cell migration, invasion and survival via the PI3K-AKT pathway [25]. Other researchers found that a combined signature of high LAMA3, LAMB3, and LAMC2 expression was a stronger predictor of poor prognosis in pancreatic adenocarcinoma than individual genes [26]. In thyroid cancer, Jung et al. found that LAMB3 was upregulated in PTC tissues and that loss of LAMB3 in PTC cells reduced cell migration and invasion via downregulation of epithelial‒mesenchymal transition-associated proteins and inhibition of matrix metalloproteinase 9 [27]. However, the detailed functions of LAMB3 in PTC are still unclear. In our study, mechanistic exploration revealed that LAMB3 was a LINC02454-coexpressed gene related to the ECM-receptor interaction pathway in thyroid carcinogenesis.

SDC4 is an important member of the family of transmembrane heparan sulfate proteoglycans, and plays a major role in the interactions between the extracellular matrix and the cell surface [28]. Studies have indicated that the function of SDC4 is highly associated with human tumorigenesis and development such as hepatocellular cancer, colorectal cancer, and ovarian cancer [29,30,31]. To our knowledge, there are few reports about the function of SDC4 in the PTC. A study showed that SDC4 gene silencing in PTC cells could suppress cell migration and invasion and promote cell apoptosis by inhibiting the activation of the Wnt/β -catenin signaling pathway [32]. These studies demonstrated that SDC4 could be considered as a tumor promoter in human cancers. However, studies on the precise molecular mechanisms study of SDC4 in PTC are still limited. In our study, SDC4 expression was significantly increased in PTC tissues. Additionally, SDC4 might be coexpressed with LINC02454 and correlated with the ECM-receptor interaction pathway in PTC.

The MAPK signaling pathway plays a vital role in several processes of tumorigenesis such as tumor cell proliferation, migration, and invasion in various cancers including thyroid cancer. IL1RAP plays a crucial role in inflammation through the IL-1, IL-33, and IL-36 signaling pathways. Importantly, IL1RAP is overexpressed on tumor cells across various cancers, supporting its potential involvement in carcinogenesis. Structurally, IL1RAP consists of an extracellular cytokine-binding domain and an intracellular signaling domain capable of activating inflammatory pathways like MAPK and NF-κB pathways [33]. Zhang et al. noted that high IL1RAP expression in Ewing sarcoma may drive Ewing sarcoma progression by mediating local invasion and metastatic capacity [34]. Another recent study showed that IL1RAP overexpression was associated with worse overall survival in pancreatic cancer patients, which was attributed to its facilitation of tumor cell viability, invasiveness, and clonogenic growth [35]. To date, there are few data about its role in thyroid cancer. Smallridge et al. found that IL1RAP was upregulated in BRAF V600E PTC compared with BRAF wild-type patients via RNA sequencing analysis [36]. However, there is currently no clear evidence of the detailed functions of IL1RAP in PTC. Our study showed that IL1RAP was highly expressed in thyroid cancer tissues compared with normal tissues. Moreover, IL1RAP seemed to be coexpressed with LINC02454 and activated the MAPK pathway in thyroid tumorigenesis.

In this work, we proposed a novel methodology to identify thyroid cancer related key genes, by integrating WGCNA, KEGG enrichment analysis and network analysis. The identified key genes were significantly differentially expressed between tumor and normal samples, and they have been proved to be related to prognosis of thyroid cancer. This method can also be utilized to study other cancers. In previous articles, the analysis usually starts with differential expression analysis, and subsequent analysis is based on genes that show differential expression [37, 38]. However, our article starts with the identification module and then searches for modules closely related to clinical characteristics of thyroid cancer. Furthermore, we integrated three different bioinformatics methods to screen out five key genes. Although these results indicate the underlying mechanism of action of LINC02454 in PTC, there are several limitations to our study. First, there are few functional studies of these candidate genes in PTC cells. Second, our study conducted the LINC02454 centered coexpression network analysis, but whether these candidate genes could be regarded as potential diagnostic and prognostic biomarkers may need further investigation. Third, the precise mechanism by which LINC02454 affects the ECM-receptor interaction and MAPK signaling remains poorly explored.

Conclusions

We conducted comprehensive bioinformatics analyses to investigate the LINC02454-related key pathways and coexpressed genes in PTC. The expression levels of 5 key genes (FN1, LAMB3, ITGA3, SDC4, and IL1RAP) were significantly upregulated in PTC tissues. In addition, FN1 and ITGA3 were correlated with poor prognosis of PTC. Mechanistic exploration revealed that key genes could affect the ECM-receptor interaction and MAPK signaling pathway in PTC pathogenesis.

Availability of data and materials

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

Abbreviations

LINC02454:

Long intergenic noncoding RNA 02454

PTC:

Papillary thyroid cancer

WGCNA:

Weighted gene coexpression network analysis

KEGG:

Kyoto Encyclopedia of Genes and Genomes

GEPIA:

The Gene Expression Profiling Interactive Analysis

References

  1. Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12–49.

    PubMed  Google Scholar 

  2. Pizzato M, Li M, Vignat J, Laversanne M, Singh D, La Vecchia C, Vaccarella S. The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020. Lancet Diabetes Endocrinol. 2022;10(4):264–72.

    PubMed  Google Scholar 

  3. LeClair K, Bell KJL, Furuya-Kanamori L, Doi SA, Francis DO, Davies L. Evaluation of gender inequity in thyroid cancer diagnosis: differences by sex in US thyroid cancer incidence compared with a meta-analysis of subclinical thyroid cancer rates at autopsy. JAMA internal medicine. 2021;181(10):1351–8.

    PubMed  Google Scholar 

  4. Chen DW, Lang BHH, McLeod DSA, Newbold K, Haymart MR. Thyroid cancer. Lancet (London, England). 2023;401(10387):1531–44.

    PubMed  Google Scholar 

  5. Boucai L, Zafereo M, Cabanillas ME. Thyroid cancer: a review. JAMA. 2024;331(5):425–35.

    CAS  PubMed  Google Scholar 

  6. Erler P, Keutgen XM, Crowley MJ, Zetoune T, Kundel A, Kleiman D, Beninato T, Scognamiglio T, Elemento O, Zarnegar R, et al. Dicer expression and microRNA dysregulation associate with aggressive features in thyroid cancer. Surgery. 2014;156(6):1342–50; discussion 1350.

    PubMed  Google Scholar 

  7. Gugnoni M, Manicardi V, Torricelli F, Sauta E, Bellazzi R, Manzotti G, Vitale E, de Biase D, Piana S, Ciarrocchi A. Linc00941 is a novel transforming growth factor β target that primes papillary thyroid cancer metastatic behavior by regulating the expression of cadherin 6. Thyroid. 2021;31(2):247–63.

    CAS  PubMed  Google Scholar 

  8. Guo K, Qian K, Shi Y, Sun T, Wang Z. LncRNA-MIAT promotes thyroid cancer progression and function as ceRNA to target EZH2 by sponging miR-150-5p. Cell Death Dis. 2021;12(12):1097.

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Tan J, Liu L, Zuo Z, Song B, Cai T, Ding D, Lu Y, Ye X. Overexpression of novel long intergenic non-coding RNA LINC02454 is associated with a poor prognosis in papillary thyroid cancer. Oncol Rep. 2020;44(4):1489–501.

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Cao Y, Li J, Du Y, Sun Y, Liu L, Fang H, Liang Y, Mao S. LINC02454 promotes thyroid carcinoma progression via upregulating HMGA2 through CREB1. FASEB J. 2023;37(12):e23288.

    CAS  PubMed  Google Scholar 

  11. Chen B, Weng Y, Li M, Bian Z, Tao Y, Zhou W, Lu H, He S, Liao R, Huang J, et al. LINC02454-CCT complex interaction is essential for telomerase activity and cell proliferation in head and neck squamous cell carcinoma. Cancer Lett. 2024;588:216734.

    CAS  PubMed  Google Scholar 

  12. Zhu Q, Zhang R, Lu F, Zhang X, Zhang D, Zhang Y, Chen E, Han F, Zha D. Cuproptosis-related LINC02454 as a biomarker for laryngeal squamous cell carcinoma based on a novel risk model and in vitro and in vivo analyses. J Cancer Res Clin Oncol. 2023;149(16):15185–206.

    CAS  PubMed  Google Scholar 

  13. Ottone T, Silvestrini G, Piazza R, Travaglini S, Gurnari C, Marchesi F, Nardozza AM, Fabiani E, Attardi E, Guarnera L, et al. Expression profiling of extramedullary acute myeloid leukemia suggests involvement of epithelial-mesenchymal transition pathways. Leukemia. 2023;37(12):2383–94.

    CAS  PubMed  Google Scholar 

  14. Chen X, Wang R, Xu T, Zhang Y, Li H, Du C, Wang K, Gao Z. Identification of candidate genes associated with papillary thyroid carcinoma pathogenesis and progression by weighted gene co-expression network analysis. Translational cancer research. 2021;10(2):694–713.

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Gu Y, Huang K, Zhang M, Teng F, Ge L, Zhou J, Xu J, Jia X. Long noncoding RNA CTD-2589M5.4 inhibits ovarian cancer cell proliferation, migration, and invasion via downregulation of the extracellular matrix-receptor interaction pathway. Cancer biotherapy and radiopharmaceuticals. 2022;37(7):580–8.

    CAS  PubMed  Google Scholar 

  16. Zhang QJ, Li DZ, Lin BY, Geng L, Yang Z, Zheng SS. SNHG16 promotes hepatocellular carcinoma development via activating ECM receptor interaction pathway. Hepatobiliary Pancreat Dis Int. 2022;21(1):41–9.

    CAS  PubMed  Google Scholar 

  17. Chen C, Ye L, Yi J, Liu T, Li Z. Correction: FN1-mediated activation of aspartate metabolism promotes the progression of triple-negative and luminal a breast cancer. Breast Cancer Res Treat. 2024;204(2):425–7.

    PubMed  Google Scholar 

  18. Hiroshima Y, Kasajima R, Kimura Y, Komura D, Ishikawa S, Ichikawa Y, Bouvet M, Yamamoto N, Oshima T, Morinaga S, et al. el targets identified by integrated cancer-stromal interactome analysis of pancreatic adenocarcinoma. Cancer Lett. 2020;469:217–27.

    CAS  PubMed  Google Scholar 

  19. Jiang Y, Liu Y, Zhang Y, Ouyang J, Feng Y, Li S, Wang J, Zhang C, Tan L, Zhong J, et al. MicroRNA-142-3P suppresses the progression of papillary thyroid carcinoma by targeting FN1 and inactivating FAK/ERK/PI3K signaling. Cell Signal. 2023;109:110792.

    CAS  PubMed  Google Scholar 

  20. Nieto HR, Thornton CEM, Brookes K, Nobre de Menezes A, Fletcher A, Alshahrani M, Kocbiyik M, Sharma N, Boelaert K, Cazier JB, et al. Recurrence of papillary thyroid cancer: a systematic appraisal of risk factors. The Journal of clinical endocrinology and metabolism. 2022;107(5):1392–406.

    PubMed  Google Scholar 

  21. Islam MK, Syed P, Dhondt B, Gidwani K, Pettersson K, Lamminmäki U, Leivo J. Detection of bladder cancer with aberrantly fucosylated ITGA3. Anal Biochem. 2021;628:114283.

    CAS  PubMed  Google Scholar 

  22. Zheng X, Du Y, Liu M, Wang C. ITGA3 acts as a purity-independent biomarker of both immunotherapy and chemotherapy resistance in pancreatic cancer: bioinformatics and experimental analysis. Funct Integr Genomics. 2023;23(2):196.

    CAS  PubMed  PubMed Central  Google Scholar 

  23. Guo K, Qian K, Shi Y, Sun T, Chen L, Mei D, Dong K, Gu S, Liu J, Lv Z, et al. Clinical and molecular characterizations of papillary thyroid cancer in children and young adults: a multicenter retrospective study. Thyroid. 2021;1(11):1693–706.

    Google Scholar 

  24. Mautone L, Ferravante C, Tortora A, Tarallo R, Giurato G, Weisz A, Vitale M. Higher integrin alpha 3 beta1 expression in papillary thyroid cancer is associated with worst outcome. Cancers. 2021;13(12):2937.

    CAS  PubMed  PubMed Central  Google Scholar 

  25. Wattanathavorn W, Seki M, Suzuki Y, Buranapraditkun S, Kitkumthorn N, Sasivimolrattana T, Bhattarakosol P, Chaiwongkot A. Downregulation of LAMB3 Altered the Carcinogenic Properties of Human Papillomavirus 16-Positive Cervical Cancer Cells. Int J Mol Sci. 2024;25(5):2535.

    CAS  PubMed  PubMed Central  Google Scholar 

  26. Sari B, Gulbey O, Hamill KJ. Laminin 332 expression levels predict clinical outcomes and chemotherapy response in patients with pancreatic adenocarcinoma. Front Cell Dev Biol. 2023;11:1242706.

    PubMed  PubMed Central  Google Scholar 

  27. Jung SN, Lim HS, Liu L, Chang JW, Lim YC, Rha KS, Koo BS. LAMB3 mediates metastatic tumor behavior in papillary thyroid cancer by regulating c-MET/Akt signals. Sci Rep. 2018;8(1):2718.

    PubMed  PubMed Central  Google Scholar 

  28. Onyeisi JOS, Lopes CC, Götte M. Syndecan-4 as a pathogenesis factor and therapeutic target in cancer. Biomolecules. 2021;11(4):503.

    CAS  PubMed  PubMed Central  Google Scholar 

  29. Yang H, Liu Y, Zhao MM, Guo Q, Zheng XK, Liu D, Zeng KW, Tu PF. Therapeutic potential of targeting membrane-spanning proteoglycan SDC4 in hepatocellular carcinoma. Cell Death Dis. 2021;12(5):492.

    CAS  PubMed  PubMed Central  Google Scholar 

  30. Jechorek D, Haeusler-Pliske I, Meyer F, Roessner A. Diagnostic value of syndecan-4 protein expression in colorectal cancer. Pathol Res Pract. 2021;222:153431.

    CAS  PubMed  Google Scholar 

  31. Kim S, Han Y, Kim SI, Lee J, Jo H, Wang W, Cho U, Park WY, Rando TA, Dhanasekaran DN, et al. Computational modeling of malignant ascites reveals CCL5-SDC4 interaction in the immune microenvironment of ovarian cancer. Mol Carcinog. 2021;60(5):297–312.

    CAS  PubMed  PubMed Central  Google Scholar 

  32. Chen LL, Gao GX, Shen FX, Chen X, Gong XH, Wu WJ. SDC4 Gene silencing favors human papillary thyroid carcinoma cell apoptosis and inhibits epithelial mesenchymal transition via Wnt/β-catenin pathway. Mol Cells. 2018;41(9):853–67.

    CAS  PubMed  PubMed Central  Google Scholar 

  33. Frenay J, Bellaye PS, Oudot A, Helbling A, Petitot C, Ferrand C, Collin B, Dias AMM. IL-1RAP, a key therapeutic target in cancer. Int J Mol Sci. 2022;23(23):14918.

    CAS  PubMed  PubMed Central  Google Scholar 

  34. Zhang HF, Hughes CS, Li W, He JZ, Surdez D, El-Naggar AM, Cheng H, Prudova A, Delaidelli A, Negri GL, et al. Proteomic screens for suppressors of anoikis identify IL1RAP as a promising surface target in Ewing Sarcoma. Cancer Discov. 2021;11(11):2884–903.

    CAS  PubMed  PubMed Central  Google Scholar 

  35. Zhang Y, Chen X, Wang H, Gordon-Mitchell S, Sahu S, Bhagat TD, Choudhary G, Aluri S, Pradhan K, Sahu P, et al. Innate immune mediator, Interleukin-1 receptor accessory protein (IL1RAP), is expressed and pro-tumorigenic in pancreatic cancer. J Hematol Oncol. 2022;15(1):70.

    CAS  PubMed  PubMed Central  Google Scholar 

  36. Smallridge RC, Chindris AM, Asmann YW, Casler JD, Serie DJ, Reddi HV, Cradic KW, Rivera M, Grebe SK, Necela BM, et al. RNA sequencing identifies multiple fusion transcripts, differentially expressed genes, and reduced expression of immune function genes in BRAF (V600E) mutant vs BRAF wild-type papillary thyroid carcinoma. J Clin Endocrinol Metab. 2014;99(2):E338-347.

    CAS  PubMed  Google Scholar 

  37. Zhao P, Zhen H, Zhao H, Huang Y, Cao B. Identification of hub genes and potential molecular mechanisms related to radiotherapy sensitivity in rectal cancer based on multiple datasets. J Transl Med. 2023;21(1):176.

    PubMed  PubMed Central  Google Scholar 

  38. Dai W, Guo C, Wang Y, Li Y, Xie R, Wu J, Yao B, Xie D, He L, Li Y, et al. Identification of hub genes and pathways in lung metastatic colorectal cancer. BMC Cancer. 2023;23(1):323.

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We would like to acknowledge the reviewers for their helpful comments on this paper.

Funding

This work was supported by Municipal Science and Technology Plan Project of Huai'an (No.HAB202014), Jiangsu Geriatric Health Research Project (LKM2022069), Special Fund of Science and Technology Bureau of Huai'an (No.HAP202105), and the National Natural Science Foundation of China (No.8200102953).

Author information

Author notes

  1. Yingjian Song and Lin Wang contributed equally to this work.

Authors and Affiliations

  1. Department of Respiratory and Critical Care Medicine, The Affiliated Huaian No. 1 People’s Hospital of Nanjing Medical University, Huaian, Jiangsu, China

    Yingjian Song

  2. Department of Breast and Thyroid Surgery, The Affiliated Huaian No. 1 People’s Hospital of Nanjing Medical University, Huaian, Jiangsu, China

    Yi Ren

  3. Department of Radiation Oncology, The Affiliated Huaian No. 1 People’s Hospital of Nanjing Medical University, Huai’an, Jiangsu, China

    Xilei Zhou

  4. Department of General Practice, The Affiliated Huaian No. 1 People’s Hospital of Nanjing Medical University, 6 Beijing Road West, Huaian, 223300, Jiangsu, China

    Lin Wang & Juan Tan

Authors
  1. Yingjian Song
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lin Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yi Ren
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xilei Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Juan Tan
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

YS and YR: performed the research, analyzed the data, and wrote the manuscript; XZ: participated in data analysis and figure preparation; JT: Conceived of this study and revised the manuscript. LW: participated in data analysis and revised the manuscript.

Corresponding author

Correspondence to Juan Tan.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Song, Y., Wang, L., Ren, Y. et al. Identification of LINC02454-related key pathways and genes in papillary thyroid cancer by weighted gene coexpression network analysis (WGCNA). Thyroid Res 17, 17 (2024). https://doi.org/10.1186/s13044-024-00205-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13044-024-00205-8

Keywords

Thyroid Research

ISSN: 1756-6614